ArticleDrug design, development and therapy2023

Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP.

Ping Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.